| Target Price | $31.62 |
| Price | $29.94 |
| Potential |
5.61%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Helmerich & Payne 2027 .
The average Helmerich & Payne target price is $31.62.
This is
5.61%
register free of charge
$37.80
26.25%
register free of charge
$25.25
15.66%
register free of charge
|
|
| A rating was issued by 26 analysts: 12 Analysts recommend Helmerich & Payne to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Helmerich & Payne stock has an average upside potential 2027 of
5.61%
register free of charge
|
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.75 | 4.09 |
| 35.89% | 9.18% | |
| EBITDA Margin | 22.89% | 21.91% |
| 25.03% | 4.28% | |
| Net Margin | -4.41% | 1.74% |
| 135.79% | 139.48% |
18 Analysts have issued a sales forecast Helmerich & Payne 2026 . The average Helmerich & Payne sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Helmerich & Payne EBITDA forecast 2026. The average Helmerich & Payne EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Helmerich & Payne Analysts have issued a net profit forecast 2026. The average Helmerich & Payne net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.66 | 0.72 |
| 148.40% | 143.37% | |
| P/E | 41.78 | |
| EV/Sales | 1.17 |
20 Analysts have issued a Helmerich & Payne forecast for earnings per share. The average Helmerich & Payne EPS is
This results in the following potential growth metrics and future valuations:
Helmerich & Payne...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Dec 17 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Dec 11 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Nov 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 17 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Dec 11 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 25 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Nov 25 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Nov 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


